U.S. markets close in 1 hour 44 minutes
  • S&P 500

    4,211.33
    +10.45 (+0.25%)
     
  • Dow 30

    34,564.82
    +100.18 (+0.29%)
     
  • Nasdaq

    13,781.25
    +44.97 (+0.33%)
     
  • Russell 2000

    2,274.67
    +1.60 (+0.07%)
     
  • Crude Oil

    66.58
    -0.27 (-0.40%)
     
  • Gold

    1,903.50
    +5.00 (+0.26%)
     
  • Silver

    27.95
    +0.01 (+0.04%)
     
  • EUR/USD

    1.2201
    +0.0001 (+0.01%)
     
  • 10-Yr Bond

    1.5890
    -0.0210 (-1.30%)
     
  • GBP/USD

    1.4190
    -0.0014 (-0.10%)
     
  • USD/JPY

    109.8100
    -0.0200 (-0.02%)
     
  • BTC-USD

    35,740.29
    -3,426.42 (-8.75%)
     
  • CMC Crypto 200

    926.22
    -72.20 (-7.23%)
     
  • FTSE 100

    7,022.61
    +2.94 (+0.04%)
     
  • Nikkei 225

    29,149.41
    +600.40 (+2.10%)
     

SHAREHOLDER ALERT: CCXI PCT ATER: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, NY / ACCESSWIRE / May 28, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

ChemoCentryx, Inc. (NASDAQ:CCXI)

If you suffered a loss, contact us at:http://www.wongesq.com/pslra-1/chemocentryx-inc-loss-submission-form?prid=16325&wire=1
Lead Plaintiff Deadline: July 6, 2021
Class Period: November 26, 2019 - May 3, 2021

Allegations against CCXI include that: (1) the study design of the Phase III ADVOCATE trial presented issues about the interpretability of the trial data to define a clinically meaningful benefit of avacopan and its role in the management of ANCA-associated vasculitis; (2) the data from the Phase III ADVOCATE trial raised serious safety concerns for avacopan; (3) these issues presented a substantial concern regarding the viability of ChemoCentryx's New Drug Application ("NDA") for avacopan for the treatment of ANCA-associated vasculitis; and (4) as a result of the foregoing, Defendants' public statements were materially false and misleading at all relevant times.

PureCycle Technologies, Inc. (NASDAQ:PCT)

If you suffered a loss, contact us at:http://www.wongesq.com/pslra-1/purecycle-technologies-inc-loss-submission-form?prid=16325&wire=1
Lead Plaintiff Deadline: July 12, 2021
Class Period: November 16, 2020 - May 5, 2021

Allegations against PCT include that: (i) the technology PureCycle licensed from Procter & Gamble is not proven and presents serious issues even at lab scale; (ii) the challenges posed by the availability and competition for the raw materials necessary to commercialize the licensed technology are significant; (iii) PureCycle's financial projections are baseless; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Aterian, Inc. (NASDAQ:ATER)

If you suffered a loss, contact us at:https://www.wongesq.com/pslra-1/aterian-inc-loss-submission-form?prid=16325&wire=1
Lead Plaintiff Deadline: July 12, 2021
Class Period: December 1, 2020 - May 3, 2021

Allegations against ATER include that: (i) the Company's organic growth is plummeting; (ii) the Company's recent, self-lauded acquisitions were overpayments for flawed assets from questionable sources; (iii) Aterian's purported artificial intelligence software is a flawed product that lacks customer interest; (iv) Aterian uses rebate programs and paid or artificial reviews to pump up their product offerings; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.

To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong



View source version on accesswire.com:
https://www.accesswire.com/649671/SHAREHOLDER-ALERT-CCXI-PCT-ATER-The-Law-Offices-of-Vincent-Wong-Reminds-Investors-of-Important-Class-Action-Deadlines